In addition to the two previously mentioned pharmacological effects, TGP demonstrates significant immunomodulatory properties in the treatment of urticaria, SS, OLP, SLE, and vitiligo (Zhao et al., 2024). The gene discussed is TGM4; the disease is synovial sarcoma.